Skip to main page content
U.S. flag

An official website of the United States government

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018 Dec;45(6):2913-2923.
doi: 10.1007/s11033-018-4358-6. Epub 2018 Sep 7.

Molecular pathways involved in microRNA-mediated regulation of multidrug resistance

Rongrong Liao  1 , Yuexia Lin  1 , Lihui Zhu  2
Affiliations
Review

Molecular pathways involved in microRNA-mediated regulation of multidrug resistance

Rongrong Liao et al. Mol Biol Rep. 2018 Dec.

Abstract

Multidrug resistance (MDR) is still a major reason for therapeutic failure in cancers. The mechanisms underlying MDR are multifactorial and are not fully understood. miRNAs are evolutionarily conserved non-coding RNAs that function as key post-transcriptional regulators of gene expression. Emerging evidence indicates a vital role of miRNAs in the resistance to cancer treatments and suggests their potential for cancer therapy, as they can modulate multiple mechanisms link to the development of MDR. This review summarizes the recent findings on the role of miRNAs in MDR, and highlights the molecular targets and mechanisms of miRNA regulated pathways in MDR. Finally, the challenges and prospects of miRNA-targeted therapies for reversing drug resistance are reviewed.

Keywords: Clinical trials; MiRNA; Pathway; Therapeutics.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Breast Cancer Res. 2014 Sep 17;16(5):435 - PubMed
    1. Mol Cancer. 2015 Nov 17;14:196 - PubMed
    1. Nat Rev Drug Discov. 2006 Mar;5(3):219-34 - PubMed
    1. Cell Cycle. 2016 Nov;15(21):2920-2930 - PubMed
    1. Oncotarget. 2014 Feb 28;5(4):944-58 - PubMed

LinkOut - more resources